ACWI vs ARKG

iShares MSCI ACWI ETF vs ARK Genomic Revolution ETF

Quick take
  • ACWI has the lower expense ratio at 0.32% vs 0.75% for ARKG.
  • ACWI pays a higher dividend yield (1.43%).

Side-by-side metrics

MetricACWIARKG
Expense ratio
Annual fee. Lower is better.
0.32%0.75%
Dividend yield
Trailing 12-month yield.
1.43%0.00%
AUM
Assets under management — bigger funds are typically more liquid.
$33.20B$1.73B
YTD return
10.89%44.53%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.972.38
P/E ratio
23.21
Last price
$157.20$43.17
Inception
Issuer
iSharesARK

ACWI top holdings

Top holdings · ACWI
NVDANVIDIA Corp4.54%
AAPLApple Inc4.17%
MSFTMicrosoft Corp2.58%
AMZNAmazon.com Inc2.27%
GOOGLAlphabet Inc Class A2.04%
2330.TWTaiwan Semiconductor Manufacturing Co Ltd1.83%
AVGOBroadcom Inc1.67%
GOOGAlphabet Inc Class C1.60%
MUMicron Technology Inc1.28%
METAMeta Platforms Inc Class A1.21%
Sector breakdown · ACWI
Real Estate1.6%
Consumer Cyclical8.7%
Basic Materials3.4%
Consumer Defensive4.7%
Technology32.7%
Communication Services8.0%
Financial Services15.9%
Utilities2.4%
Industrials10.8%
Energy3.5%
Healthcare8.3%

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp9.15%
TEMTempus AI Inc Class A common stock7.64%
ABSIAbsci Corp7.01%
TXG10x Genomics Inc Ordinary Shares - Class A7.00%
CRSPCRISPR Therapeutics AG6.56%
PSNLPersonalis Inc6.19%
BEAMBeam Therapeutics Inc4.34%
GHGuardant Health Inc4.28%
NTRANatera Inc4.11%
ILMNIllumina Inc3.98%
Sector breakdown · ARKG
Healthcare100.0%

About ACWI

ACWI (iShares MSCI ACWI ETF) is Global equities including US and developed/emerging markets. Managed by iShares, the fund carries $33.2B in assets under management, an expense ratio of 0.32%, a dividend yield of 1.43%. Its largest holding is NVIDIA Corp (NVDA), which represents 4.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.